Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lyra Therapeutics

0.1020
-0.0018-1.73%
Pre-market: 0.11200.0100+9.80%08:53 EDT
Volume:761.73K
Turnover:78.94K
Market Cap:6.72M
PE:-0.07
High:0.1053
Open:0.1038
Low:0.1010
Close:0.1038
Loading ...
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 16, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2022

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2022

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Oct 26, 2022

Major Issues Report

8-K - Current report
Sep 12, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 17, 2022

Major Issues Report

8-K - Current report
May 31, 2022

Major Issues Report

8-K - Current report
May 18, 2022

Correspondence

CORRESP [Cover] - Correspondence
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2022

Major Issues Report

8-K - Current report
Apr 22, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 22, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership